Nonpeptidyl mimetics of superoxide dismutase in clinical therapies for diseases

Cellular and Molecular Life Sciences

Volumn 57, Issue 11, 2000, Pages 1489-1492

  Salvemini, D ^a   Riley, D P ^a  

^a MetaPhore Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRON COMPLEX; MANGANESE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOOXIDATION; CANCER; CARDIOVASCULAR DISEASE; CATALYST; CELL RESPIRATION; DRUG STRUCTURE; INFLAMMATION; NEUROLOGIC DISEASE; OXIDATIVE STRESS; SECOND MESSENGER;

EID: 0033788436     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000632     Document Type: Article

References (40)

1. Superoxide dismutase: An enzymic function for erythrocuprein
2. Superoxide dismutases. An adaptation to a paramagnetic gas
3. Superoxide accelerates DNA damage by elevating free-iron levels
4. Ferritin as a source of iron and protection from iron-induced toxicities
5. Release of iron from ferritin by cardiotoxic anthracycline antibiotics
6. Hydrodioxyl (perhydroxyl), peroxyl, and hydroxyl radical-initiated lipid peroxidation of large unilamellar vesicles (liposomes): Comparative and mechanistic studies
7. Perhydroxyl radical (HOO) initiated lipid peroxidation. The role of fatty acid hydroperoxides
8. Mechanisms and biological relevance of lipid peroxidation initiation
9. Mechanism of site-selective DNA nicking by the hydrodioxyl (perhydroxyl) radical
10. Ras, superoxide and signal transduction
11. Mitogenic Signaling mediated by oxidants in Ras-transformed fibroblasts
12. Sustained limitation by superoxide dismutase of canine myocardial injury due to ischemia followed by reperfusion
13. Interstitial equilibration of superoxide dismutase correlates with it protective effect in the isolated rabbit heart
14. Superoxide dismutase: Rationale for use in reperfusion injury and inflammation
15. Effect of superoxide dismutase derivative on cold-induced brain edema
16. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing superoxide dismutase
17. Human copper-zinc superoxide dismutase transgenic mice are highly resistant injury after focal cerebral ischemia
18. Prevention of reperfusion-induced, free radical-mediated acute endothelial injury by super oxide dismutase as an effective tool to delay/prevent chronic renal allograft Failure: A review
19. Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema
20. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion
21. Anti-inflammatory effects of recombinant human manganese superoxide dismutase on adjuvant arthritis in rats
22. Amyotrophic lateral sclerosis and structural defects in CU, Zn superoxide dismutase
23. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
24. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
25. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells
26. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death
27. SOD2: A new type of tumor-suppressor gene?
28. Increased manganese superoxide dismutase expression suppresses the malignant human melanoma cells
29. Expression of manganese superoxide dismutase promotes cellular differentiation
30. Suppression of fibrosarcoma metastasis by elevated expression of manganese dismutase
31. Suppressive effect of recombinant human Cu, Zn-superoxide dismutase on lung metastasis of murine tumor cells
32. Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells
33. Clastogenic factors in plasma of HIV-1 infected patients activate HIV-1 replication in vitro: Inhibition by superoxide dismutase
34. Superoxide dismutase mimics as future therapeutics
35. Functional mimics of superoxide dismutase enzymes as therapeutic agents
36. Metalloporphyrin class of therapeutic catalytic antioxidants
37. Computer-Aided Design (CAD) of synzymes: Use of molecular mechanics (MM) for the rational design of superoxide dismutase mimics
38. Rational design of synthetic enzymes and their potential utility as human pharmaceuticals: Development of Mn(II)-based superoxide dismutase mimics
39. A non-peptidyl mimic of superoxide dismutase with therapeutic activity in rats